Top Texas Biotech Startups (88)

OncoNano Medicine is a biotech company that develops pH-activated compounds that digitalize and exploit the variability of pH in disease.

NeuroX1 is a target ID and drug discovery platform leveraging proprietary generative AI to create the next generation of therapeutics for neurological disorders.

Hyperion Biotechnology, Inc. is a woman-owned, service-disabled veteran-owned small business headquartered in San Antonio, TX. As a biomedical and clinical research company, we deliver scientific and technology driven solutions. By growing our business to support a wide range of services, we are a reliable source for support services for our U.S. Department of Defense, federal government and other customers. Hyperion conducts...

Vivione is a TSX Venture Exchange listed biosciences company focused on the commercialization of its proprietary RAPID-B system.

NeuScience uses computer vision to detect phenotypic signals, resulting in novel, pan-cancer biomarkers.

Vascular Perfusion Solutions develops medical devices designed to preserve and resuscitate vascularized organs.

Taysha Gene Therapies is on a mission to eradicate monogenic CNS disease. With a singular focus on developing curative medicines, we hope to rapidly translate our treatments from bench to bedside. We have combined our team’s proven experience in gene therapy drug development and commercialization with the world-class UT Southwestern Gene Therapy Program to quickly and efficiently build an extensive,...

Neurolink is an early-stage company developing a novel therapy for the treatment of epilepsy.

Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.

Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies that target neoantigens arising from genomic mutations. We have developed proprietary, rapid, cost-effective solutions to deliver tumor-specific killer T cells to large cancer...

Othram enables human identification from difficult evidence such as touch DNA, rootless hair, and decades-old bones. We specialize in "unsolvable" cold cases.

We are a late-stage biopharmaceutical company focused on the development and commercialization of novel personalized therapeutics to treat cancer.

Conceptual MindWorks, Inc. (CMI) is a diversified basic and applied research, consulting, and software engineering company with over 23 years of providing health-related software, bioinformatics, biotechnology, scientific, and technical solutions to the public and private sectors.

We are a team of data science experts who use AI to accelerate high-impact projects in high-stakes industries.Our AI team brings technology and perspectives from multiple disciplines, including computational biology, genomics, bioinformatics, pharmacology, neuroscience, physics, engineering, and software development. We partner with our clients to integrate AI capabilities to improve care, enhance discoveries, and enable data-driven decisions.

BioGenix grew out of the recognition of the important potential of regenerative medicine in giving hope to patients who suffer from past injuries, chronic conditions, or degenerative disease. Out of this potential grew the demand for safe, reliable, ethically sound regenerative products -- and BioGenix was up to the task. Working directly with hospitals participating in umbilical cord tissue donation programs...

Colossal is a breakthrough bioscience and genetic engineering company that builds radical new technologies to advance the field of genomics. Colossal creates disruptive technologies for extinct species restoration, critically endangered species protection and the repopulation of critical ecosystems that support the continuation of life on Earth. The company is the first to apply CRISPR technology for the purposes of species...

InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.

Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO).

Nanospectra Biosciences develops particle-based therapies for the selective and precise thermal destruction of solid tumors.

We are on a mission to be the leader in adult stem cell research and therapies by developing and distributing FDA approved therapies that are safe, ethical, and affordable; by developing technologies that allow you to safely and affordable bank your own stem cells; by setting industry standards for quality processing and testing of stem cell therapeutics.